Available to sourceHuman Prescription DrugGastrointestinal

Sodium Acetate

Active ingredients · Sodium Acetate Anhydrous

164 mg/mL · Injection

By Hikma Pharmaceuticals USA Inc.

NDC: 0641-6263
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

10 VIAL in 1 CARTON (0641-6263-10) / 100 mL in 1 VIAL (0641-6263-01)NDC 0641-6263-10Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.